Vericel Corp: Form 10-K for the period ended Dec 31, 2014
Filed with the SEC on Mar 25, 2015 and accepted by EDGAR at Mar 25, 2015, 17:09 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2014-01-01 to 2014-12-31 | $28.8m | us-gaap:SalesRevenueNet |
| Cost of revenue | 12 months2014-01-01 to 2014-12-31 | $17.3m | us-gaap:CostOfGoodsSold |
| Gross profit | 12 months2014-01-01 to 2014-12-31 | $11.5m | us-gaap:GrossProfit |
| Research and development | 12 months2014-01-01 to 2014-12-31 | $21.3m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2014-01-01 to 2014-12-31 | $13.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2014-01-01 to 2014-12-31 | −$23.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2014-01-01 to 2014-12-31 | $6.0k | us-gaap:InterestExpense |
| Net income | 12 months2014-01-01 to 2014-12-31 | −$19.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2014-01-01 to 2014-12-31 | −$2.23 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months2014-01-01 to 2014-12-31 | −$25.4m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 12 months2014-01-01 to 2014-12-31 | $829.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2014-12-31 | $30.3m | us-gaap:Cash |
| Current assets | At period end2014-12-31 | $41.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2014-12-31 | $47.6m | us-gaap:Assets |
| Current liabilities | At period end2014-12-31 | $11.8m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2014-12-31 | $35.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-15-022712. Last ingested by Listed: Nov 14, 2026, 12:33 ET. Listed shows no prices and gives no investment advice.